home
Weblog

 Brazilian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property

On Monday, 18 January 2010, Brazil delivered the following statement to the 126th session of the Executive Board of the World Health Organization (WHO) under agenda item 4.3 "public health, innovation and intellectual property". In her intervention, the delegate of Brazil stressed,

"Access to medication is a critical issue. The Global Strategy refers to the Doha Declaration on TRIPS and Public Health and states the very fact that the price of medicines is one of the factors that hinder access to treatment. Medicines cannot be treated like other products. Strategies to reduce the price of drugs must be pursued, including proposals to de-link the costs of research and development from the price of drugs."

To read more, acess KEI-

Comments
0 comment
Add a comment
pre-moderation

This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?

Text of your message:
(To create paragraphs, you simply leave blank lines.)
Hypertext link (optional)
(If your message refers to an article published on the web or to a page providing further information, please enter the title of the page and its URL below).
Subject:
 
URL:
 
Who are you? (optional)
Your name (or alias):
 
Your e-mail address: